We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Bayer Selects Genedata’s Bioinformatic Platform for its Target Research and Biomarker Activities
News

Bayer Selects Genedata’s Bioinformatic Platform for its Target Research and Biomarker Activities

Bayer Selects Genedata’s Bioinformatic Platform for its Target Research and Biomarker Activities
News

Bayer Selects Genedata’s Bioinformatic Platform for its Target Research and Biomarker Activities

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Bayer Selects Genedata’s Bioinformatic Platform for its Target Research and Biomarker Activities"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Genedata has announced the expansion of its collaboration with Bayer HealthCare to include multiple sites in Germany and the US. Genedata will deliver a software solution for characterizing targets and biomarkers.

"Genedata have helped resolve bottlenecks in our research processes, an achievement reflecting their sound grasp of drug discovery," says Professor Andreas Busch, Head of Global Drug Discovery, Bayer HealthCare.

The collaboration has expanded to complement the activities of Bayer HealthCare’s target and biomarker research program.

Biomarkers will help identify compounds likely to be effective at later drug development stages, enabling Bayer HealthCare to focus its attention on the most promising therapeutic leads.

"In addition to strong software functionality, we require scalability and solid result information management," explained Dr. Joe Catino, Head of Discovery US, Bayer Pharmaceuticals Corp. in West Haven.

Genedata’s solutions incorporate industry-standard database technologies with an advanced three tier client-server architecture.

This has facilitated efficient deployment and integration with Bayer HealthCare’s global research informatics infrastructure.

"We are delighted that Bayer HealthCare has chosen Genedata’s proven IT solutions to support its target and biomarker research efforts," says Dr. Othmar Pfannes, Chairman and President of Genedata.

Earlier phases of the collaboration have been expanded to create a global research informatics solution for Bayer Healthcare.

Dr. Pfannes added, "The collaboration demonstrates the usefulness of Genedata Expressionist® and Genedata Phylosopher® for target identification, diagnostics, toxicology and biomarker studies."

Advertisement